Pritzker Group Private Capital today announced that it has named leaders for its healthcare team. Michael Dal Bello, former managing director with Blackstone Group, joins the firm as healthcare investment partner and former Cardinal Health executive Michael A. Lynch joins as healthcare operating partner.
Dal Bello and Lynch have the mandate to source, invest in and oversee a group of healthcare companies for Pritzker Group Private Capital.
Dal Bello, 42, brings 13 years of direct investing experience. During his tenure at Blackstone, Dal Bello helped lead sourcing efforts in healthcare and insurance, investing more than $7 billion of equity capital in 13 transactions. Dal Bello also served on ten corporate boards, working with management teams to drive value through operational improvements, acquisitions and divestitures. Dal Bello will be based in Pritzker Group’s Los Angeles office and is expected to begin his new role in early December.
Lynch, 52, most recently served as chief executive officer of Cardinal Health’s medical segment, a $10 billion business with more than 15,000 employees in nine countries serving hospitals, clinics and other sites of care worldwide. Lynch is a seasoned global executive with 28 years of strategic and operational experience in medical products manufacturing, sourcing and distribution. He held leadership roles in several Cardinal Health businesses, consistently growing them through acquisitions, alliances, organic revenue and operational improvements. Lynch is based in Pritzker Group’s Chicago office.
Led by Tony and J.B. Pritzker, Pritzker Group has a 10 year history of acquiring leading middle-market companies in the manufactured products, services and healthcare sectors. Pritzker Group Private Capital’s healthcare interests include both product and services businesses across several healthcare industry sub-sectors. The firm’s permanent, proprietary capital base makes it particularly attractive as a partner for family- and entrepreneur-owned businesses in its target industry sectors.
“We’ve attracted a world-class team to continue expanding our family of companies,” said Paul Carbone, Pritzker Group Private Capital managing partner. “Michael Dal Bello and Michael Lynch’s long track records of success align well with our focus on growth and value creation.”
Pritzker Group Private Capital’s family of companies currently includes Clinical Innovations, which develops, manufactures and markets women’s health medical devices focused on the labor and delivery market. Earlier this year, Clinical Innovations named former Hologic executive Shacey Petrovic as its president and chief executive officer.
Dal Bello earned an MBA from Harvard Business School, an MA from Oxford University and undergraduate degrees from the Wharton School and the College of Arts and Sciences at the University of Pennsylvania. He is a member of the Council on Foreign Relations.
Lynch, a graduate of Cornell University, sits on the Boston Centerless board of directors and is a former member of the AdvaMed board of directors and its executive committee.
About Pritzker Group
Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which is the largest technology venture investor based in the Midwest; and Asset Management, which partners with top-performing investment managers across global public markets.
Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and healthcare sectors. The firm’s permanent, proprietary capital base allows for efficient decision making, broad flexibility with transaction structure and investment horizon, and alignment with management teams focused on creating long-term value. Pritzker Group brings significant resources, expertise and credibility in building businesses and is an ideal partner for entrepreneur- and family-owned companies.